CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

/C O R R E C C I O N -- Bridge to Life, Ltd./

RegulatorypositiveVitaSmart™Positive
AI Analysis

Summary

Bridge to Life announces a correction to its press release regarding NICE's recommendation for NHS funding of VitaSmart™. The correction was issued on August 27, 2026.

Outcome Details

NICE (UK National Institute for Health and Care Excellence) recommends NHS funding for VitaSmart™

Importance:6/10
Sentiment:
0.75
NICE recommendationNHS fundingUK regulatorycorrection notice

Read the original article

Published by PR Newswire Biotech on August 28, 2026 3:13 PM

Read Original